SSO Education Series: Neoadjuvant Trials in Pancreas Cancer: Part 2 – The North American Perspective
Release Date: 02/20/2025
SurgOnc Today®
In this episode of SurgOnc Today, Dr. Miral Grandhi of Rutgers University and Dr. Neha Lad of Mount Sinai Medical Center—both members of the HPB Disease Site Working Group—provide a curated summary of the most impactful hepato-pancreato-biliary malignancy papers presented at the Society of Surgical Oncology’s 2025 Annual Meeting in Tampa, Florida. The discussion is moderated by Dr. Patricio Polanco of UT Southwestern Medical Center, who also serves as Vice Chair of the HPB Disease Site Working Group.
info_outlineSurgOnc Today®
In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Pedro Dos Santos the results of a study that examined whether patients of the lowest income quartile with stage IA NSCLC experience worse survival after resection when compared to higher-income patients, as well as other identified survival disparities, as reported in as reported in the article article, "Money Matters: The Effect of Income on Postsurgical Outcomes in Stage IA Non-small Cell Lung Cancer.”
info_outlineSurgOnc Today®
In this podcast, Dr. Adam Khader (Richmond VA Medical Center & Assistant Professor at VCU School of Medicine) moderates a focused discussion with Dr. Jula Veerapong (UC San Diego Health) and Dr. Zachary Brown (NYU Langone Medical Center) on the clinical assessment and treatment of goblet cell carcinoma (GCC). The panel explores how evolving pathologic classifications impact management, the role of staging, and treatment considerations including systemic therapy and surgery. This episode provides practical, expert-driven insights for clinicians managing patients with this rare appendiceal...
info_outlineSurgOnc Today®
In this episode of SurgOnc Today's Surgical Oncology Insight series, Dr. Peter Kingham, Section Editor of the Global Oncology Editorial Board section, discusses with Dr. Olusegun Alatise the the landscape of hepato-pancreato-biliary disease in West Africa and the available infrastructure to mitigate it, as reported in his article, "Starting a Hepato-Pancreato-Biliary surgery program from scratch: Closing the gap in West Africa."
info_outlineSurgOnc Today®
In this episode of SurgOnc Today, Dr. Olga Kantor from Brigham and Women's Hospital and Dr. Taiwo Adesoye from MD Anderson Cancer Center discuss the breast track highlights of the SSO 2025 Annual Meeting, focusing on a few potentially practice changing trials presented at the meeting. In case you missed the meeting, be sure to check out the On Demand content, now available at .
info_outlineSurgOnc Today®
In this episode, Dr. Kimberly Brown from The University of Texas at Austin Dell Medical School moderates a discussion with Dr. Thuy Tran from the University of California Irvine about the FDA approval of Lifileucel.
info_outlineSurgOnc Today®
In this episode, Dr. Anna Weiss from the University of Rochester moderates a discussion with Dr. Lola Fayanju at the University of Pennsylvania, Dr. Rita Mukhtar at UCSF and Laurie B. Hutcheson from The Lobular Breast Cancer Alliance about surgical management of invasive lobular carcinoma. This histological subtype poses challenges for systemic management and is often underrepresented on conventional breast imaging with concomitant potential for understaging.
info_outlineSurgOnc Today®
We’re bringing the heat as Dr. Laura Enomoto, Dr. Melanie Ongchin and Dr. Alissa Greenbaum discuss key highlights and updates in Peritoneal Surface Malignancy and HIPEC presented at the 2025 SSO Annual Meeting. This episode explores evolving evidence, multidisciplinary approaches, and clinical trials shaping the future of care in this complex disease space
info_outlineSurgOnc Today®
Join us on SurgOnc Today as we delve into the complexities of surgical treatment for stage IV gastric cancer. This episode explores the latest strategies and considerations for patients with advance disease including patients with positive peritoneal cytology, peritoneal carcinomatosis, liver metastasis and para-aortic nodal disease. We discuss the evolving role of surgery in improving outcomes for these patients. In this episode of SurgOnc today, Ahmed Dehal and Erin Ward from the SSO GI disease site working group Interview Dr. Lordick From University of Leipzig and Dr. Badgwell From MD...
info_outlineSurgOnc Today®
In this episode of SurgOnc Today, we hear from three experts Drs. Rebecca Gladdy, Alessandro Gronchi, and Christina Roland in the work up, treatment and follow-up of patients presenting with vascular leiomyosarcomas, a rare soft tissue tumor with special technical considerations for surgical management.
info_outlineIn this episode of SurgOnc Today®, Dr. Rebecca Snyder, from the UT MD Anderson Cancer Center, and Dr. Akhil Chawla, from Northwestern University, both members of the HPB disease site working group, are joined by Dr. Cristina Ferrone, from Cedars Sinai Medical Center, and Dr. Steven Gallinger, from the University of Toronto. We will discuss the details, similarities, and differences of their respective clinical trials for neoadjuvant therapy for pancreatic adenocarcinoma, ALLIANCE A021806, and NeoPancONE.
References/Resources: